Role of Canagliflozin on CD34+ Cells in Patients With Type 2 Diabetes
Clinical trial NCT02964585 · COMPLETED
Trial details
- NCT number
- NCT02964585
- Sponsor
- George Washington University
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2020-01-01
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.